AVITA Medical, Inc. 8-K

What Happened

• AVITA Medical (RCEL) announced it issued a warrant to Perceptive Credit Holdings V, LP under the Company’s five-year senior secured Credit Agreement. Stockholders approved the warrant at the Annual Meeting on June 3, 2026, and the Company issued the warrant on June 5, 2026.
• The Credit Agreement provides up to $60 million in senior secured financing ($50 million available at closing and an additional $10 million available at the Company’s discretion by March 31, 2027, subject to a net revenue condition).

Key Details

• Warrant terms: initial right to purchase 500,000 shares of common stock at an exercise price of $3.4019 per share.
• Incremental vesting: if the $10M additional commitment is drawn, an extra 150,000 shares become issuable under the warrant at the same exercise price.
• Registration and legal review: Warrant Shares will be registered on the Company’s Form S-3 (File No. 333-294790); legal opinion from K&L Gates LLP is included as an exhibit.
• Relevant dates: Credit Agreement disclosed Jan 13, 2026; annual meeting June 3, 2026; warrant issued June 5, 2026; deadline to request additional $10M commitment is March 31, 2027.

Why It Matters

• Liquidity: the credit facility provides up to $60M of financing, which supports the company’s cash needs and operations.
• Potential dilution: the warrant could increase share count by 500,000 (or up to 650,000 if the additional commitment is drawn) if exercised, at $3.4019 per share — investors should factor possible dilution into valuation and ownership calculations.
• Clarity and governance: the warrant issuance was approved by stockholders and the underlying Warrant Shares are registered, which reduces uncertainty about future issuance mechanics.